Cardiolyse works with university hospitals, research groups and industry on ECG-derived biomarkers, algorithm co-development and clinical validation — bringing a CE Class IIa analytics engine, hundreds of ECG parameters and more than ten years of ECG research.
Partners bring the clinical question, the cohort and the outcomes. Cardiolyse brings the ECG analysis, the engineering and the validation experience.
Each collaboration answers a different question — from outcome prediction to workflow in a hospital setting.
We define the clinical question, the cohort, the outcomes and the ECG data together.
ECG recordings are shared under an agreed data protection framework, pseudonymised where possible.
Cardiolyse processes the recordings and delivers ECG parameters and scores as structured data.
Your team links the results to outcomes. We support the statistics, methods and publication.
University hospitals, research groups, CROs and industry partners. Recent work includes the University Medical Center Mainz, Oxford University Hospitals and GVM Care & Research.
Yes. For research, results are delivered as structured data with the ECG parameters and scores in scope, ready for your statistical analysis.
Ownership, publication rights and data use are agreed in the collaboration agreement before the work starts.
Yes. Cardiolyse regularly joins consortia as the ECG analytics and validation partner. See EU Projects for current interests.
Data is processed under GDPR-aligned terms with ISO 27001-aligned security, and pseudonymised wherever the study allows.
Tell us about the cohort and the outcome. We will suggest how Cardiolyse can contribute.
